TABLE 2.

Summary of clinical trials of liver stem cells for liver disease.

Title	Status	NCT number	Cell source	Desease	Link
Safety study of HepaStem for the treatment of urea cycle disorders (UCD) and Crigler-najjar syndrome (CN)	Completed	NCT01765283	HHALPC, heterologous human adult liver derived progenitor cells	Urea cycle disorders Crigler najjar syndrome	https://ClinicalTrials.gov/show/NCT01765283
Human fetal liver cell transplantation in chronic liver failure	Completed	NCT01013194	Human fetal liver cell transplantation. Cell source: Non-purified and non-selected fetal liver cells from fetuses aborted between the 16 and 26th week of gestation.	Liver cirrhosis	https://ClinicalTrials.gov/show/NCT01013194
Improvement of liver function in liver cirrhosis Patients after autologous mesenchymal stem cell injection:a Phase I-II clinical trial	Completed	NCT00420134	Progenitor of hepatocyte drived from Mesenchymal stem cell	Liver failure cirrhosis	https://ClinicalTrials.gov/show/NCT00420134